Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07904936

Fresh Versus Vitrified-Warmed Donor Oocytes: Embryological and Clinical Outcomes

Sponsor: Center for Reproductive Medicine Bocian

View on ClinicalTrials.gov

Summary

This multicenter retrospective observational study compares embryological and clinical outcomes following treatment with fresh versus vitrified-warmed donor oocytes at Bocian Fertility Clinic centers in Poland. The study focuses on a standardized allocation strategy in which recipients are intended to receive six mature (metaphase II, MII) donor oocytes. In the vitrified-warmed group, oocytes are cryopreserved at the MII stage and subsequently warmed for use. Oocytes lost during warming are not routinely replaced, allowing the study to evaluate the consequences of warming-related losses within the initial allocation. The study will assess fertilization, embryo development, usable blastocyst yield, the probability of obtaining an embryo for transfer, and live birth following the first embryo transfer originating from the allocated oocytes. Clinical effectiveness will be evaluated from the initial oocyte allocation, including cycles in which no embryo transfer occurs. The objective is to determine whether fresh and vitrified-warmed donor-oocyte strategies are associated with differences in embryological efficiency and the likelihood of live birth when the initial number of mature allocated oocytes is standardized.

Official title: From Six Allocated Mature Donor Oocytes to Live Birth: A Multicenter Retrospective Cohort Study Comparing Fresh and Vitrified-Warmed Oocyte Donation Strategies

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

3000

Start Date

2026-03-01

Completion Date

2028-06

Last Updated

2026-10-29

Healthy Volunteers

No

Interventions

PROCEDURE

Fresh Donor Oocyte ICSI

Recipients underwent routine ICSI using fresh mature donor oocytes. Under the standard allocation strategy, six MII oocytes were allocated to each recipient. No treatment procedures were assigned or modified for research purposes.

PROCEDURE

Vitrified-Warmed Donor Oocyte ICSI

Recipients underwent routine ICSI using donor oocytes previously vitrified at the MII stage. Six vitrified MII oocytes were allocated for warming. Oocytes lost during warming were not routinely replaced. No treatment procedures were assigned or modified for research purposes.

Locations (1)

Bocian Fertility Clinic

Szczecin, West Pomeranian Voivodeship, Poland